Final Program in it's entirety - MyGirlsBlood

Recommendations

Info

Monday, July 12, 2010 Congress Sessions cont’d n Examination of Differential T Regulatory Lymphocyte Responses Following Human FIX Gene Therapy in a Novel Mouse Model Expressing Defective Human Factor IX Compared to Factor IX Knockout Mice Hu G1 , Monahan P1 , Gui T1 , Velander W2 , Stafford D1 1University of North Carolina at Chapel Hill, U.S.A., 2University of Nebraska-Lincoln, U.S.A. n Distribution of von Willebrand Disease (VWD) Types in 197 Families from the French National Reference Center for VWD (CRMW): Type 1 is not the most Frequent within “True” VWD Fressinaud E1 , Goudemand J2 , Boisseau P3 , Ternisien C3 , Itzhar N1 , Dreyfus M4 1 2 Hopital Antoine Beclere, University Hospital of Lille, 3University Hospital of Nantes, 4University Hospital of Bicêtre, France n The European Network of Rare Bleeding Disorders (EN-RBD) Project: Results of 3-Years Analysis Peyvandi F1 , Menegatti M1 , Palla R1 , Siboni SM1 , Halimeh S2 , Pergantou H3 , Celkan T4, Gilmore R5 , Mikovic D6 , Benedik-Dolnicar M7 , Giangrande P8 1A. Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Università degli Studi di Milano and Luigi Villa Foundation, Milan, Italy, 2MVZ Labor Duisburg GmbH - Duisburg, Germany, 3Haemophillia Center, Haemostasis Unit, Agia Sofia Children’s Hospital, Athens, Greece, 4Department of Pediatric Hematology- Oncology, Cerrahpasa Medical Faculty of Istanbul University, Istanbul, Turkey, 5National Centre for Hereditary Coagulation Disorders, St James's Hospital, Dublin, Ireland, 6Haemostasis Department and Haemophilia Center, Blood Transfusion Institute of Serbia, Belgrade, Serbia, 7National Haemophilia Center, University Children’s Hospital, Ljubljana, Slovenia, 8Oxford Haemophilia & Thrombosis Centre, Nuffield Department of Clinical Medicine, University of Oxford, U.K. n Electronic Bleeding Questionnaire: A Novel Approach in the Diagnosis of Mild Bleeding Disorders Hamilton A1 , Scovil S2 , Elbatarny H1 , Othman M1 1Laurentian University- St Lawrence College, 2Biomotion Laboratory, Queen's University, Kingston, ON, Canada 26 n Thrombin Generation in Patients with a Bleeding Tendency of Unknown Origin Ay C, Haselböck J, Laczkovics C, Koder S, Pabinger I Clinical Division of Haematology and Haemostaseology, Department of Medicine I, Medical University of Vienna, Austria n Clinical Bleeding Episodes in Women with Rare Bleeding Disorders: Results from the European Network of Rare Bleeding Disorders (EN-RBD) Project Mikovic D1 , Siboni SM2 , Benedik-Dolnicar M3 , Bidlingmaier C4 , Celkan T5 , Gilmore R6 , Pergantou H7 , Giangrande P8 , Peyvandi F2 1Haemostasis Department and Haemophilia Center, Blood Transfusion Institute of Serbia, Belgrade, Serbia, 2A Bianchi Bonomi Hemophilia and Thrombosis Center, Fondazione IRCCS Ca’ Granda, Ospedale Maggiore Policlinico, Università degli Studi di Milano and Luigi Villa Foundation, Milan, Italy, 3National Haemophilia Center, University Children’s Hospital, Ljubljana, Slovenia, 4Pediatric Hemophilia and Thrombosis Centre, Dr. von Hauner‘s Children‘s University Hospital, Munich, Germany, 5Department of Pediatric Hematology-Oncology, Cerrahpasa Medical Faculty of Istanbul University, Istanbul, Turkey, 6National Centre for Hereditary Coagulation Disorders, St James's Hospital, Dublin, Ireland, 7Haemophillia Center, Haemostasis Unit, Agia Sofia Children’s Hospital, Athens, Greece, 8Oxford Haemophilia & Thrombosis Centre, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom M2.3 – MULTIDISCIPLINARY≤ Importance of Psychosocial Support in the Treatment of People with Bleeding Disorders and Their Families Room: Puerto Madero Chair: Frederica Cassis, Brazil n How NMO Leaders Can Promote Psychosocial Services for Their Patients Ed Kuebler, U.S.A. n Psychosocial Needs of an Inhibitor Patient Alison Inder, New Zealand n Methods of Support for Children & Their Families Silvina Grana, Argentina n Importance of Integrating Psychosocial Discipline into Comprehensive Care Frederica Cassis, Brazil
Congress Sessions cont’d M2.4 – MUSCULOSKELETAL Hemophilia A and VWD Room: Ceibo (1st floor) Chair: David Lillicrap, Canada n Lessons Learnt from Type 1 VWD Studies David Lillicrap, Canada n Assay Design and Use of Chromogenic Factor VIII Assays Steffen Rosen, Sweden n Laboratory Detection of Inhibitors to FVIII and Other Clotting Factors Bert Verbruggen, the Netherlands M2.5 - MULTIDISCIPLINARY≤ Home Treatments and Self Infusion: Strategies of Delivery Room: Belgrano Chair: Bongi Mbele, South Africa n How to Prepare for Home Infusion Bongi Mbele, South Africa n Teaching Techniques James Munn, U.S.A. n Port and Infusion Karin Lindvall, Sweden n Challenges in Developing Countries Carmen Cunho Mello Rodrigues, Brazil M2.6 - MULTIDISCIPLINARY≤ Personal and Social Development of People with Bleeding Disorders Room: Montserrat Chair: Susan Cutter, U.S.A. n Prospects and Job Opportunities of Persons with Bleeding Disorders Antonio F. Gómez Cavallini, Argentina n Role of NMO Defending Peoples Rights David Silva, Spain n Psychosocial Care & Education for the Patient with Bleeding Disorders Susan Cutter, U.S.A. 15:45 – 16:30 POSTER PRESENTATIONS (see poster index for titles and authors) 16:30 – 18:00 CONCURRENT SESSIONS M3.1 – MEDICAL≤ Applications of Genetics Room: Buenos Aires Chair: Paula James, Canada n Genetic Testing in Hemophilia A: Clinical Relevance Johannes Oldenburg, Germany n Role of Genetic Diagnosis of VWD Paula James, Canada n New Genetic Strategies in Bleeding Disorders (GWAS) Jorge DiPaola, U.S.A. M3.2 – MEDICAL≤ New Developments in Lab Diagnosis and Monitoring Room: Puerto Madero Chair: Steve Kitchen, U.K. n Update in Bleeding Disorders (Including 1 Stage and 2 Stage FVIII Assays) Steve Kitchen, U.K. n Standardization of Platelet Function Testing in Bleeding Disorders Catherine Hayward, Canada n Potential Utility of Thrombin Generation Testing in Bleeding Disorders Claude Negrier, France M3.3 - MULTIDISCIPLINARY≤ Making the Case for Effective Clotting Factor Therapy in an Era of Health Technology Assessment Room: Belgrano Chair: David Page, Canada n An Introduction to Health Technology Assessment David Page, Canada n From Cryo to Concentrates Triroj Krutvecho, Thailand 27 Monday, July 12, 2010
Page 1 and 2: Hemophilia Saturday, July 10 - Wedn
Page 3 and 4: Pre-Congress Sessions cont’d 10:3
Page 5 and 6: Pre-Congress Sessions cont’d 15:0
Page 7 and 8: Congress Sessions cont’d S1.6 - M
Page 9 and 10: Congress Sessions cont’d S2.5 - M
Page 11: Congress Sessions cont’d n Long T
Page 15 and 16: Congress Sessions cont’d Tuesday,
Page 17 and 18: Congress Sessions cont’d 14:15 -
Page 19 and 20: Congress Sessions cont’d T3.4 - M
Page 21 and 22: Congress Sessions cont’d n Inhibi
Page 23 and 24: Congress Sessions cont’d W2.4 - L
Page 25 and 26: Index of Speakers cont’d Halimeh,
Page 27 and 28: Index of Poster Presenters Sunday a
Page 29 and 30: Index of Poster Presenters cont’d
Page 63 and 64:
Index of Poster Presenters cont’d
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
show all

Final Program in it's entirety - MyGirlsBlood

Create successful ePaper yourself

Delete template?

Save as template?